OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer

Clinical trial NCT05248789 · TERMINATED

Trial details

NCT number: NCT05248789
Sponsor: Binhui Biopharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Bladder Carcinoma

Start date: 2022-05-25
Primary completion: 2024-10-28
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.